WASHINGTON – The U.S. Supreme Court has declined to review a $70 million compensatory damages award given to a Tennessee plaintiff for failure to warn of side effects tied to the anti-psychotic drug Risperdal, while another legal fight on the subject of punitive damages against Johnson & Johnson looms in the case.